What is she best known for?
The fields of study she is best known for:
Elisabeth Kremmer mainly investigates Cell biology, Molecular biology, Immunology, T cell and Gene silencing.
Her Cell biology research is multidisciplinary, relying on both CC chemokine receptors and Receptor.
Her Molecular biology research incorporates themes from Polymerase, Transcriptional regulation, Antibody, Monoclonal antibody and RNA polymerase II.
Her work carried out in the field of Immunology brings together such families of science as Lamina propria, Small intestine and CD40.
Her T cell research incorporates elements of Lymphocyte homing receptor, Cytotoxic T cell, Cellular differentiation and Effector.
Elisabeth Kremmer has included themes like Lipid peroxidation, Regulation of gene expression, microRNA and Argonaute in her Gene silencing study.
Her most cited work include:
- CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. (2063 citations)
- Follicular B Helper T Cells Express Cxc Chemokine Receptor 5, Localize to B Cell Follicles, and Support Immunoglobulin Production (1121 citations)
- A Putative Chemokine Receptor, BLR1, Directs B Cell Migration to Defined Lymphoid Organs and Specific Anatomic Compartments of the Spleen (1019 citations)
What are the main themes of her work throughout her whole career to date?
Elisabeth Kremmer focuses on Cell biology, Molecular biology, Immunology, Biochemistry and Virology.
Elisabeth Kremmer combines subjects such as Genetics, Receptor and Mutant with her study of Cell biology.
Her studies deal with areas such as Gene expression, Gene, T cell and Antibody, Monoclonal antibody as well as Molecular biology.
As part of one scientific family, Elisabeth Kremmer deals mainly with the area of Immunology, narrowing it down to issues related to the Cancer research, and often Cancer.
Elisabeth Kremmer works in the field of Biochemistry, namely Proteases.
Her specific area of interest is Virology, where Elisabeth Kremmer studies Virus.
She most often published in these fields:
- Cell biology (37.92%)
- Molecular biology (34.29%)
- Immunology (13.77%)
What were the highlights of her more recent work (between 2013-2021)?
- Cell biology (37.92%)
- Molecular biology (34.29%)
- Biochemistry (12.21%)
In recent papers she was focusing on the following fields of study:
Her primary areas of study are Cell biology, Molecular biology, Biochemistry, Cancer research and Immunology.
Her work carried out in the field of Cell biology brings together such families of science as Sperm and Mutant.
Her Molecular biology study combines topics from a wide range of disciplines, such as Immunohistochemistry, Gene expression, Transcription factor, RNA polymerase II and Monoclonal antibody.
Her research in Immunohistochemistry intersects with topics in Antibody and Western blot.
Her Cancer research study incorporates themes from Cancer, B-cell lymphoma, Colitis and Vascular permeability.
When carried out as part of a general Immunology research project, her work on Cytokine and C-C chemokine receptor type 7 is frequently linked to work in TRAF1, therefore connecting diverse disciplines of study.
Between 2013 and 2021, her most popular works were:
- C9orf72 FTLD/ALS-associated Gly-Ala dipeptide repeat proteins cause neuronal toxicity and Unc119 sequestration (213 citations)
- Cleavage of roquin and regnase-1 by the paracaspase MALT1 releases their cooperatively repressed targets to promote T(H)17 differentiation (177 citations)
- Quantitative analysis and clinico-pathological correlations of different dipeptide repeat protein pathologies in C9ORF72 mutation carriers (151 citations)
In her most recent research, the most cited papers focused on:
Her scientific interests lie mostly in Cell biology, Molecular biology, Biochemistry, Neurodegeneration and C9orf72.
Her biological study spans a wide range of topics, including RNA-binding protein, Presenilin and Amyloid precursor protein.
Her Molecular biology research is multidisciplinary, incorporating elements of Signal transducing adaptor protein, Nuclear protein, Transcription factor, Wild type and Regulation of gene expression.
Her study on Neurodegeneration also encompasses disciplines like
- Loss function, which have a strong connection to Amyloid, Alzheimer's disease and Bioinformatics,
- Inclusion bodies, which have a strong connection to Cancer research, RNA-Binding Protein FUS, Transportin 1, Arginine and Methylation.
Her work deals with themes such as C9orf72 Protein and Pathology, which intersect with C9orf72.
In Pathology, Elisabeth Kremmer works on issues like Biomarker, which are connected to Amyotrophic lateral sclerosis.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
